Attached files

file filename
EX-10.1 - EXHIBIT 10.1 - Gadsden Properties, Inc.s103164_ex10-1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K/A

 

Amendment No. 1

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

January 8, 2016

Date of Report (Date of earliest event reported)

 

PhotoMedex, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   0-11635   59-2058100

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Ident. No.)

         
100 Lakeside Drive, Suite 100, Horsham, Pennsylvania   19044
(Address of principal executive offices)   (Zip Code)

 

(610) 208-1991

Registrant’s telephone number, including area code

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

 

 

 

 

Explanatory Note

 

This Current Report on Form 8-K/A of PhotoMedex, Inc. (the “Company”) amends the Current Report on Form 8-K of the Company dated January 8, 2016 and filed with the Securities and Exchange Commission on January 8, 2016 (the “Original Filing”). The sole purpose of this amendment is to provide a revised version of Exhibit 10.1 to include certain previously redacted information. The revised version of Exhibit 10.1 filed herewith replaces Exhibit 10.1 filed with the Original Filing. No disclosure was changed, and no other amendments are made to the Original Filing.

 

Item 9.01Financial Statements and Exhibits.

 

(d)Exhibits:

 

10.1Credit Card Receivables Advance Agreement, dated December 21, 2015, between PhotoMedex, Inc. and its subsidiaries Radiancy, Inc., PhotoMedex Technology, Inc., and Lumiere, Inc., and CC Funding, a division of Credit Cash NJ, LLC.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PHOTOMEDEX, INC.
     
Dated: May 5, 2016    
     
  By: /s/  Dolev Rafaeli  
    Dolev Rafaeli
    Chief Executive Officer

 

 

 

 

EXHIBIT INDEX

 

Exhibit Number   Description
     
10.1   Credit Card Receivables Advance Agreement, dated December 21, 2015, between PhotoMedex, Inc. and its subsidiaries Radiancy, Inc., PhotoMedex Technology, Inc., and Lumiere, Inc., and CC Funding, a division of Credit Cash NJ, LLC.